Nvidia and AMD agree to pay 15% of China chip sales to U.S. government

Nvidia and AMD have reportedly agreed to remit 15% of their China chip sales revenue to the U.S. government as a condition for export licenses, an unprecedented move for U.S. technology export controls traditionally based on national security. This arrangement, which follows the recent lifting of a ban on Nvidia's H20 AI chip sales to China, introduces a new, revenue-generating dimension to U.S. tech policy aimed at Beijing, potentially impacting future trade dynamics for semiconductor firms.

Analysis

A reported agreement requires U.S. chipmakers Nvidia and AMD to remit 15 percent of their revenue from chip sales in China to the U.S. government as a condition for receiving export licenses. This marks an unprecedented shift in U.S. policy, which has traditionally based technology export controls on national security grounds rather than as a revenue-generation tool. For the companies, this arrangement introduces a material impact on gross margins from the strategically important Chinese market, a factor reflected in the negative per-ticker sentiment scores (-0.4 for both NVDA and AMD). Nvidia's official statement frames the concession as a necessary measure to ensure American leadership in the global AI technology race, following the recent reversal of a U.S. government ban on its H20 AI chip sales to China. The lack of comment from AMD and the White House, combined with the story's developing nature, introduces significant uncertainty around the final implementation and potential scope of this new regulatory framework.

Key Decisions for Investors

• Investors should immediately model a potential 15% gross revenue reduction on China sales for both NVDA and AMD to assess the direct impact on forward earnings estimates and valuation multiples.
• Monitor for official confirmation from the companies or the U.S. government, as this policy could set a significant precedent for other U.S. technology sectors exporting critical hardware to China, introducing a new layer of regulatory risk.
• Re-evaluate the net benefit of Chinese market access for these chipmakers, as the substantial revenue share could erode profitability and alter the competitive landscape against non-U.S. rivals within China.